ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that...
Hence then, the article about enea tech and biomedical foundation invests 15 million in tethis to develop new diagnostic methods in oncology using liquid biopsy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy )
Also on site :
- She’s Gone From Indie Rocker to Unlikely Pop Star. Now She’s Back With Her First Album Since the Big Change.
- Three Bills to Reform Insurance Claims Abuses and Help Homeowners Keep Their Insurance Pass Final Committee, Head to CA Assembly Floor, Says Consumer Watchdog
- 1994 Rock Ballad, About Love Gone Wrong, Is Suddenly Going Viral 29 Years After the Singer’s Tragic Death at Age 30